Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas.
Shiroishi MS, Erickson BJ, Hu LS, Barboriak DP, Becerra L, Bell LC, Boss MA, Boxerman JL, Cen S, Cimino L, Fan Z, Keenan KE, Kirsch JE, Ameli N, Nazemi S, Quarles CC, Rosen MA, Rodriguez L, Schmainda KM, Zahlmann G, Zhou Y, Obuchowski N, Wu O; RSNA QIBA Dynamic Susceptibility Contrast MRI Biomarker Committee. Shiroishi MS, et al. Radiology. 2024 Dec;313(3):e232555. doi: 10.1148/radiol.232555. Radiology. 2024. PMID: 39656118 Review.
Standardized evaluation of the extent of resection in glioblastoma with automated early post-operative segmentation.
Luque L, Skogen K, MacIntosh BJ, Emblem KE, Larsson C, Bouget D, Helland RH, Reinertsen I, Solheim O, Schellhorn T, Vardal J, Mireles EEM, Vik-Mo EO, Bjørnerud A. Luque L, et al. Among authors: emblem ke. Front Radiol. 2024 May 22;4:1357341. doi: 10.3389/fradi.2024.1357341. eCollection 2024. Front Radiol. 2024. PMID: 38840717 Free PMC article.
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients.
Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P. Blakstad H, et al. Among authors: emblem ke. J Neurooncol. 2024 Aug;169(1):137-145. doi: 10.1007/s11060-024-04709-z. Epub 2024 May 19. J Neurooncol. 2024. PMID: 38762830 Free PMC article.
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study.
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P. Blakstad H, et al. Among authors: emblem ke. Neurooncol Pract. 2023 Oct 3;11(1):36-45. doi: 10.1093/nop/npad063. eCollection 2024 Feb. Neurooncol Pract. 2023. PMID: 38222046 Free PMC article.
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.
Kim AE, Lou KW, Giobbie-Hurder A, Chang K, Gidwani M, Hoebel K, Patel JB, Cleveland MC, Singh P, Bridge CP, Ahmed SR, Bearce BA, Liu W, Fuster-Garcia E, Lee EQ, Lin NU, Overmoyer B, Wen PY, Nayak L, Cohen JV, Dietrich J, Eichler A, Heist R, Krop I, Lawrence D, Ligibel J, Tolaney S, Mayer E, Winer E, Perrino CM, Summers EJ, Mahar M, Oh K, Shih HA, Cahill DP, Rosen BR, Yen YF, Kalpathy-Cramer J, Martinez-Lage M, Sullivan RJ, Brastianos PK, Emblem KE, Gerstner ER. Kim AE, et al. Among authors: emblem ke. Neuro Oncol. 2024 May 3;26(5):965-974. doi: 10.1093/neuonc/noad236. Neuro Oncol. 2024. PMID: 38070147 Free PMC article. Clinical Trial.
Optimization of Q.Clear reconstruction for dynamic 18F PET imaging.
Lysvik EK, Mikalsen LTG, Rootwelt-Revheim ME, Emblem KE, Hjørnevik T. Lysvik EK, et al. Among authors: emblem ke. EJNMMI Phys. 2023 Oct 20;10(1):65. doi: 10.1186/s40658-023-00584-1. EJNMMI Phys. 2023. PMID: 37861929 Free PMC article.
Radiological features of brain hemorrhage through automated segmentation from computed tomography in stroke and traumatic brain injury.
MacIntosh BJ, Liu Q, Schellhorn T, Beyer MK, Groote IR, Morberg PC, Poulin JM, Selseth MN, Bakke RC, Naqvi A, Hillal A, Ullberg T, Wassélius J, Rønning OM, Selnes P, Kristoffersen ES, Emblem KE, Skogen K, Sandset EC, Bjørnerud A. MacIntosh BJ, et al. Among authors: emblem ke. Front Neurol. 2023 Sep 28;14:1244672. doi: 10.3389/fneur.2023.1244672. eCollection 2023. Front Neurol. 2023. PMID: 37840934 Free PMC article.
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.
Kim AE, Lou KW, Giobbie-Hurder A, Chang K, Gidwani M, Hoebel K, Patel JB, Cleveland MC, Singh P, Bridge CP, Ahmed SR, Bearce BA, Liu W, Fuster-Garcia E, Lee EQ, Lin NU, Overmoyer B, Wen PY, Nayak L, Cohen JV, Dietrich J, Eichler A, Heist R, Krop I, Lawrence D, Ligibel J, Tolaney S, Mayer E, Winer E, Perrino CM, Summers EJ, Mahar M, Oh K, Shih HA, Cahill DP, Rosen BR, Yen YF, Kalpathy-Cramer J, Martinez-Lage M, Sullivan RJ, Brastianos PK, Emblem KE, Gerstner ER. Kim AE, et al. Among authors: emblem ke. bioRxiv [Preprint]. 2023 Aug 28:2023.08.25.554868. doi: 10.1101/2023.08.25.554868. bioRxiv. 2023. PMID: 37693537 Free PMC article. Preprint.
92 results